Primary and secondary drug screening assays for Friedreich ataxia (Q39442440)

12 September 2017

title

Primary and secondary drug screening assays for Friedreich ataxia (English)

1 reference

12 September 2017

0 references

1 reference

M Grazia Cotticelli

1 reference

12 September 2017

Lynn Rasmussen

1 reference

12 September 2017

Nicole L Kushner

1 reference

12 September 2017

Sara McKellip

1 reference

12 September 2017

Melinda Ingrum Sosa

1 reference

12 September 2017

Anna Manouvakhova

1 reference

12 September 2017

Shuang Feng

1 reference

12 September 2017

E Lucile White

1 reference

12 September 2017

Joseph A Maddry

1 reference

12 September 2017

Jill Heemskerk

1 reference

12 September 2017

Robert J Oldt

1 reference

12 September 2017

Lea F Surrey

1 reference

12 September 2017

Rachel Ochs

1 reference

12 September 2017

Robert B Wilson

1 reference

12 September 2017

language of work or name

1 reference

15 November 2011

1 reference

Journal of Biomolecular Screening

12 September 2017

published in

1 reference

12 September 2017

1 reference

12 September 2017

1 reference

12 September 2017

page(s)

303-313

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

12 September 2017

1 reference

Clinical and genetic abnormalities in patients with Friedreich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Components involved in assembly and dislocation of iron-sulfur clusters on the scaffold protein Isu1p

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Oxidative stress in patients with Friedreich ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Effects of pH and metal ions on antioxidative activities of catechins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

Safety, Tolerability, and Pharmacokinetics of High-Dose Idebenone in Patients With Friedreich Ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057111427949

21 January 2018

Identifiers

DOI

10.1177/1087057111427949

1 reference

12 September 2017

1 reference